glp-1 conference Exploring New Frontiers in Nutrition and Metabolic Health at the UC Davis Discovery Forum Hematology Case Conference: “GLP-1 Agonists

Their evaluation of the effect of GLP-1 was also aided by their access to RIAs for GLP-1 (Holst 2024)

You dont have to go it alone

The first incretin to be discovered was glucose-dependent insulinotropic polypeptide (GIP)

Calorie and hydration concerns during breastfeeding Beyond the direct medication transfer question, there is a practical concern about caloric intake

Slow weight loss is not a disadvantage, and in many cases its actually more favorable for body composition in long-term maintenance

Dual Agonists Under Investigation Tirzepatide (Mounjaro) was approved by the FDA on May 13, 2022 for the treatment of type 2 diabetes in adults, making it the first and only GIP/GLP-1 receptor agonist